|
Subject
|
Sex
|
Age (years)
|
Medication
|
|---|
|
RA patient
|
|
1
|
Female
|
55
|
NSAID (diclofenac)
|
|
2
|
Female
|
53
|
None
|
|
3
|
Female
|
72
|
Anti-TNF-α (adalimumab)
|
|
4
|
Female
|
ND
|
None
|
|
5
|
Female
|
44
|
Anti-TNF-α (infliximab)
|
|
6
|
Female
|
80
|
DMARDs (methotrexate and resochine)
|
|
7
|
Female
|
35
|
Anti-TNF-α (infliximab)
|
|
8
|
Male
|
61
|
Anti-TNF-α (infliximab)
|
|
9
|
Male
|
51
|
DMARD (methotrexate); steroid (cortisone)
|
|
Healthy donor
|
|
1
|
Female
|
30
|
None
|
|
2
|
Female
|
26
|
None
|
|
3
|
Female
|
38
|
None
|
|
4
|
Male
|
27
|
None
|
- RA, rheumatoid arthritis; NSAID, nonsteroidal anti-inflammatory drug; DMARD, disease-modifying anti-rheumatic drug; ND, not determined.
